WPRIM Management System> DCMS> Blood Research> 2022> 57

Volume: 57

1. Treatment of indolent lymphoma Page:S120—S129
2. Recent advances in treatments of adult immune thrombocytopenia Page:S112—S119
3. Advances in prophylaxis and treatment of invasive fungal infections:perspectives on hematologic diseases Page:S101—S111
4. Advances in laboratory assessment of thrombosis and hemostasis Page:S93—S100
5. Genetics and genomics of bone marrow failure syndrome Page:S86—S92
6. Diagnosis and management of thrombocytopenia in pregnancy Page:S79—S85
7. Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT Page:S75—S78
8. Human acute myeloid leukemia stem cells: evolution of concept Page:S67—S74
9. Update on primary plasma cell leukemia Page:S62—S66
10. Basic immunohistochemistry for lymphoma diagnosis Page:S55—S61
11. Overview of inherited bone marrow failure syndromes Page:S49—S54
12. Challenging issues in the management of cancer-associated venous thromboembolism Page:S44—S48
13. Recent advances in the management of immune-mediated thrombotic thrombocytopenic purpura Page:S37—S43
14. FLT3 mutations in acute myeloid leukemia: a review focusing on clinically applicable drugs Page:S32—S36
15. Update on the POEMS syndrome Page:S27—S31
16. Diagnosis and management of monoclonal gammopathy of clinical significance Page:S20—S26
17. Diagnostic workup of inherited platelet disorders Page:S11—S19
18. Evaluation and management of platelet transfusion refractoriness Page:S6—S10
19. Assessing frailty using comprehensive geriatric assessment in older patients with hematologic malignancy Page:S1—S5
20. Dasatinib-induced reversible pulmonary arterial hypertension in a pediatric patient with BCR/ABL1+ lymphoblastic lymphoma from chronic myeloid leukemia Page:80—84
21. Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second Page:76—80
22. COVID-19 pneumonia concurrent with newly diagnosed chronic myelogenous leukemia Page:74—75
23. Myeloproliferative neoplasm with basophilia and abnormality of platelet-derived growth factor receptor a translocation: a case report Page:69—74
24. Myelofibrotic and leukemic transformation in 2016 WHO-defined Philadelphia-negative myeloproliferative neoplasm Page:59—68
25. Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen Page:51—58
26. Clinical characteristics and treatment outcomes of children and adolescents with aggressive mature B-cell lymphoma: a single-center analysis Page:41—50
27. Prophylaxis for invasive fungal infection in pediatric patients with allogeneic hematopoietic stem cell transplantation Page:34—40
28. Induction-related mortality in adolescents and young adults with acute lymphoblastic leukemia in a resource-limited setting: do treatment-related complications create more impact than disease biology? Page:29—33
29. Management of immune thrombocytopenia: 2022 update of Korean experts recommendations Page:20—28
30. IDH1/2 mutations in acute myeloid leukemia Page:13—19
31. Convalescent plasma in COVID-19: renewed focus on the timing and effectiveness of an old therapy Page:6—12
32. ALK-positive anaplastic large cell lymphoma that presented as pleural effusion Page:5—5
33. Appearances are deceiving: immature lymphocytes in Leishmaniasis Page:4—4
34. A call for vigilance: thrombotic thrombocytopenic syndrome caused by mRNA COVID-19vaccine associated with muscle weakness Page:1—3
35. An infant with severe hemophilia A with intracranial hemorrhage mistaken for child abuse: a case report Page:169—171
36. Enrichment of TP53 alterations within GCB-like DNA subclassifications of diffuse large B-cell lymphoma after transition from de-novo to relapsed or refractory disease Page:164—169
37. A rare case of primary plasma cell leukemia exhibiting the small-cell variant of plasma cells Page:161—164
38. Philadelphia-positive (PH+) acute lymphoblastic leukemia (ALL):developing strategies for curing this stubborn disease Page:158—161
39. Favorable outcomes with durable chimerism after hematopoietic cell transplantation using busulfan and fludarabine-based reduced-intensity conditioning for pediatric patients with hemophagocytic lymphohistiocytosis Page:152—157
40. Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea Page:144—151
41. Immunoglobulin repletion during blinatumomab therapy does not reduce the rate of secondary hypogammaglobulinemia and associated infectious risk Page:135—143
42. The impact of nucleic acid testing as a blood donor screening method in transfusion-associated hepatitis C among children with bleeding disorders in Indonesia: a single-center experience Page:129—134
43. Diffuse large B-cell lymphoma (DLBCL) is infiltrated with activated CD8+ T-cells despite immune checkpoint signaling Page:117—128
44. Multidisciplinary supportive care in systemic light chain amyloidosis Page:106—116
45. Diabetes mellitus and diabetic nephropathy: a review of the literature on hemostatic changes in coagulation and thrombosis Page:101—105
46. Chronic myeloid leukemia: a type of MPN Page:95—100
47. Korean clinical practice guidelines for the diagnosis of hereditary hemolytic anemia Page:86—94
48. Smudge cells in CD200+,TP53 mutated leukemic mantle cell lymphoma Page:85—85
49. Vaccine-induced immune thrombotic thrombocytopenia (VITT) with cerebral venous sinus thrombosis (CVST): a case report from Malaysia Page:244—246
50. A rare case of pediatric immune thrombocytopenia with secondary antiphospholipid syndrome in Korea Page:241—243
51. Low-level somatic JAK2 V617F mutation in myelodysplastic/ myeloproliferative neoplasm with ring sideroblasts, and thrombocytosis with co-mutated SF3B1 and CALR Page:239—241
52. Comparative evaluation of the developed targeted RNA sequencing system and a commercialized test panel Page:235—238
53. Cabot ring-like faggot cells in acute promyelocytic leukemia Page:174—174
54. Ofloxacin-induced recurrent pancytopenia Page:173—173
55. Association of CD40 gene polymorphisms and immune thrombocytopenic purpura in the adult Egyptian population Page:229—234
56. Endothelial nitric oxide synthase Glu298Asp gene polymorphism in the cases of idiopathic thrombocytopenic purpura Page:223—228
57. Chest multidetector computed tomography imaging of COVID-19pneumonia patients with hematologic malignancies Page:216—222
58. Early diagnosis of Gaucher disease in Korean patients with unexplained splenomegaly: a multicenter observational study Page:207—215
59. Treatment for relapsed acute promyelocytic leukemia: what is the best post-remission treatment? Page:197—206
60. Relevance of flow cytometric categorization and end-of-induction measurable residual disease assessment in pediatric and adult T-lymphoblastic leukemia patients Page:175—196
61. NK-cell trogocytosis of CD19 antigen: a rare B-ALL MRD mimicker Page:249—249
62. FVIII inhibitor surveillance in children with hemophilia A in Indonesia:a report from the Indonesian Pediatric Hematology-Oncology Working Group Page:272—277
63. Prognostic impact of total body irradiation dose in pediatric acute lymphoblastic leukemia patients treated with allogeneic hematopoietic stem cell transplantation in second complete remission Page:256—263
64. Reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for patients with myelofibrosis Page:264—271
65. Unusual peripheral T-cell lymphoma, displaying NOS and flower cells in the blood, and CNS involvement Page:248—248
66. Red blood cells from COVID-19 patients suffer from increased oxidative stress and may have increased lactate influx Page:294—296
67. High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea Page:290—293
68. Comparison of serum and urine free light chain analysis in clinical diagnosis Page:284—289
69. Rapid development of lower leg compartment syndrome following firearm injury in a patient with moderate hemophilia B Page:281—284
70. Detection of NUP214-ABL1 translocation using BCR-ABL1 dual color FISH probes in T-cell acute lymphoblastic leukemia–an illustrative report and review of literature Page:278—281
71. Epigenetic and genetic investigation of SOCS-1 gene in patients with multiple myeloma Page:250—255
72. Various inclusions in chronic lymphocytic leukemia/small lymphocytic lymphoma Page:247—247

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.